Fergus J. Couch

Full Professor(heuristic)

BRCA gene mutations in cancer · Genetics

h-index119

i10-index462

Publications1,332

Citations61,761

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 137

Supplementary Figure S2 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026-06-17
Supplementary Figure S4 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026-06-17
Supplementary Figure S3 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026-06-17
Supplementary Figure S5 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026-06-17
Supplementary Figure S1 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026-06-17
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification
Nature Communications · 2026-04-09 · 1 citations
Supplementary Methods and Tables 1-3 from Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives
2025-12-17
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in <i>BRCA1</i> or <i>BRCA2</i>
JNCI Journal of the National Cancer Institute · 2025-12-13 · 2 citations
Supplemental Table 4 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Figure 2 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Table 1 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Figure 1 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Table 6 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Table 2 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Table 3 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplemental Table 5 from Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts
2025-11-26
Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
2025-11-25
Figure S4 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
2025-11-25
Figure S7 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
2025-11-25
Figure S2 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
2025-11-25

Open author page on OpenAlex →